Benmerah A, Lamaze C, Bègue B, Schmid S L, Dautry-Varsat A, Cerf-Bensussan N
Developpement Normal et Pathologique du Systeme Immunitaire, Institut National de la Sante et de la Recherche Medicale U 429, Hopital Necker-Enfants Malades, 75743 Paris Cedex 15, France.
J Cell Biol. 1998 Mar 9;140(5):1055-62. doi: 10.1083/jcb.140.5.1055.
We have previously shown that the protein Eps15 is constitutively associated with the plasma membrane adaptor complex, AP-2, suggesting its possible role in endocytosis. To explore the role of Eps15 and the function of AP-2/Eps15 association in endocytosis, the Eps15 binding domain for AP-2 was precisely delineated. The entire COOH-terminal domain of Eps15 or a mutant form lacking all the AP-2-binding sites was fused to the green fluorescent protein (GFP), and these constructs were transiently transfected in HeLa cells. Overexpression of the fusion protein containing the entire COOH-terminal domain of Eps15 strongly inhibited endocytosis of transferrin, whereas the fusion protein in which the AP-2-binding sites had been deleted had no effect. These results were confirmed in a cell-free assay that uses perforated A431 cells to follow the first steps of coated vesicle formation at the plasma membrane. Addition of Eps15-derived glutathione-S-transferase fusion proteins containing the AP-2-binding site in this assay inhibited not only constitutive endocytosis of transferrin but also ligand-induced endocytosis of epidermal growth factor. This inhibition could be ascribed to a competition between the fusion protein and endogenous Eps15 for AP-2 binding. Altogether, these results show that interaction of Eps15 with AP-2 is required for efficient receptor-mediated endocytosis and thus provide the first evidence that Eps15 is involved in the function of plasma membrane-coated pits.
我们之前已经表明,蛋白质Eps15与质膜衔接蛋白复合物AP-2组成性相关,提示其在内吞作用中可能发挥作用。为了探究Eps15的作用以及AP-2/Eps15结合在内吞作用中的功能,精确界定了Eps15与AP-2的结合结构域。将Eps15的整个COOH末端结构域或缺乏所有AP-2结合位点的突变形式与绿色荧光蛋白(GFP)融合,并将这些构建体瞬时转染到HeLa细胞中。含有Eps15整个COOH末端结构域的融合蛋白过表达强烈抑制转铁蛋白的内吞作用,而删除了AP-2结合位点的融合蛋白则没有作用。这些结果在无细胞试验中得到证实,该试验使用穿孔的A431细胞来追踪质膜上包被小泡形成的第一步。在此试验中添加含有AP-2结合位点的Eps15衍生的谷胱甘肽-S-转移酶融合蛋白不仅抑制了转铁蛋白的组成性内吞作用,还抑制了表皮生长因子的配体诱导的内吞作用。这种抑制作用可归因于融合蛋白与内源性Eps15之间对AP-2结合的竞争。总之,这些结果表明Eps15与AP-2的相互作用是高效受体介导的内吞作用所必需的,从而提供了首个证据表明Eps15参与质膜包被小窝的功能。